REMITLY GLOBAL INC (RELY)

US75960P1049 - Common Stock

23.17  +0.18 (+0.78%)

After market: 23.17 0 (0%)

Fundamental Rating

4

Overall RELY gets a fundamental rating of 4 out of 10. We evaluated RELY against 99 industry peers in the Financial Services industry. RELY has a great financial health rating, but its profitability evaluates not so good. RELY is valued quite expensive, but it does show an excellent growth.



1

1. Profitability

1.1 Basic Checks

In the past year RELY has reported negative net income.
RELY had a positive operating cash flow in the past year.
In the past 5 years RELY always reported negative net income.
RELY had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of RELY (-6.83%) is worse than 89.90% of its industry peers.
RELY has a Return On Equity of -10.51%. This is amonst the worse of the industry: RELY underperforms 80.81% of its industry peers.
Industry RankSector Rank
ROA -6.83%
ROE -10.51%
ROIC N/A
ROA(3y)-11.32%
ROA(5y)-13.36%
ROE(3y)-18.03%
ROE(5y)-25.45%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

RELY has a Gross Margin of 65.81%. This is in the better half of the industry: RELY outperforms 77.78% of its industry peers.
In the last couple of years the Gross Margin of RELY has grown nicely.
RELY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.55%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

RELY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RELY has been increased compared to 1 year ago.
RELY has a worse debt/assets ratio than last year.

2.2 Solvency

RELY has an Altman-Z score of 8.94. This indicates that RELY is financially healthy and has little risk of bankruptcy at the moment.
RELY has a better Altman-Z score (8.94) than 92.93% of its industry peers.
RELY has a debt to FCF ratio of 0.03. This is a very positive value and a sign of high solvency as it would only need 0.03 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.03, RELY belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
RELY has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.00, RELY belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Altman-Z 8.94
ROIC/WACCN/A
WACC9.14%

2.3 Liquidity

RELY has a Current Ratio of 2.66. This indicates that RELY is financially healthy and has no problem in meeting its short term obligations.
RELY has a Current ratio of 2.66. This is amongst the best in the industry. RELY outperforms 80.81% of its industry peers.
RELY has a Quick Ratio of 2.66. This indicates that RELY is financially healthy and has no problem in meeting its short term obligations.
RELY has a better Quick ratio (2.66) than 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 2.66
Quick Ratio 2.66

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.66% over the past year.
RELY shows a strong growth in Revenue. In the last year, the Revenue has grown by 35.19%.
RELY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 54.31% yearly.
EPS 1Y (TTM)39.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105%
Revenue 1Y (TTM)35.19%
Revenue growth 3Y54.31%
Revenue growth 5YN/A
Sales Q2Q%39.27%

3.2 Future

RELY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.62% yearly.
RELY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.63% yearly.
EPS Next Y61.36%
EPS Next 2Y39.77%
EPS Next 3Y33%
EPS Next 5Y37.62%
Revenue Next Year33.41%
Revenue Next 2Y28.73%
Revenue Next 3Y25.82%
Revenue Next 5Y20.63%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

RELY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RELY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

RELY's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 51.38
EV/EBITDA N/A

4.3 Compensation for Growth

RELY's earnings are expected to grow with 33.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.77%
EPS Next 3Y33%

0

5. Dividend

5.1 Amount

RELY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

REMITLY GLOBAL INC

NASDAQ:RELY (1/6/2025, 5:52:05 PM)

After market: 23.17 0 (0%)

23.17

+0.18 (+0.78%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)N/A N/A
Inst Owners82.69%
Inst Owner Change0%
Ins Owners5.75%
Ins Owner Change-0.72%
Market Cap4.59B
Analysts82.35
Price Target24.61 (6.21%)
Short Float %4.51%
Short Ratio4.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)75.41%
Min EPS beat(2)37.61%
Max EPS beat(2)113.2%
EPS beat(4)4
Avg EPS beat(4)45.14%
Min EPS beat(4)4.47%
Max EPS beat(4)113.2%
EPS beat(8)7
Avg EPS beat(8)28.63%
EPS beat(12)8
Avg EPS beat(12)8.42%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.16%
Min Revenue beat(2)-0.54%
Max Revenue beat(2)2.86%
Revenue beat(4)1
Avg Revenue beat(4)-0.51%
Min Revenue beat(4)-3.7%
Max Revenue beat(4)2.86%
Revenue beat(8)4
Avg Revenue beat(8)1.05%
Revenue beat(12)7
Avg Revenue beat(12)1.55%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.05%
PT rev (3m)16.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.88%
EPS NY rev (1m)0%
EPS NY rev (3m)21.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.95%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.9
P/FCF 51.38
P/OCF 43.96
P/B 7.27
P/tB 8.15
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)0.45
FCFY1.95%
OCF(TTM)0.53
OCFY2.27%
SpS5.94
BVpS3.19
TBVpS2.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.83%
ROE -10.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.81%
FCFM 7.59%
ROA(3y)-11.32%
ROA(5y)-13.36%
ROE(3y)-18.03%
ROE(5y)-25.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.55%
GM growth 5YN/A
F-Score7
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Debt/EBITDA N/A
Cap/Depr 95.78%
Cap/Sales 1.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.66
Quick Ratio 2.66
Altman-Z 8.94
F-Score7
WACC9.14%
ROIC/WACCN/A
Cap/Depr(3y)86.86%
Cap/Depr(5y)127.85%
Cap/Sales(3y)1.01%
Cap/Sales(5y)2.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105%
EPS Next Y61.36%
EPS Next 2Y39.77%
EPS Next 3Y33%
EPS Next 5Y37.62%
Revenue 1Y (TTM)35.19%
Revenue growth 3Y54.31%
Revenue growth 5YN/A
Sales Q2Q%39.27%
Revenue Next Year33.41%
Revenue Next 2Y28.73%
Revenue Next 3Y25.82%
Revenue Next 5Y20.63%
EBIT growth 1Y37.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year193.53%
EBIT Next 3Y59.95%
EBIT Next 5Y42.45%
FCF growth 1Y224.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y259.09%
OCF growth 3YN/A
OCF growth 5YN/A